Role of Gender on the Outcomes of ST-Elevation Myocardial Infarction Patients Following Primary Coronary Angioplasty

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2021 Oct 18

PMID 34660090

Citations 1

Authors

Aigin Heydari

Aryan Zahergivar

Peyman Izadpanah

Gilberto Aquino

Jeremy R Burt

Affiliations

Soon will be listed here.

Abstract

Background There are considerable differences in the prevalence of coronary artery disease (CAD) and its cardiovascular risk factors between men and women. Due to the significance of gender as a factor that potentially affects cardiovascular disorders and patient outcomes, the present study aimed to assess the baseline characteristics and outcomes of CAD patients in terms of gender distribution. Methods All consecutive patients diagnosed with ST-elevation myocardial infarction (MI) who had undergone primary percutaneous coronary intervention (PCI) in the previous two years in a comprehensive cardiology center were included. Data were retrospectively collected from the hospital record files. Color Doppler echocardiography, valvular involvement, and the type of coronary vessel involvement were also evaluated. Results In total, 557 consecutive patients (437 men and 120 women) were included with a mean age of 59.37 ± 26.23 years and 64.07 ± 11.60 years for men and women, respectively (p = 0.004). The prevalence of mitral regurgitation (MR) and tricuspid regurgitation (TR) was significantly higher among women than men. Conclusion Female patients who suffered from CAD and underwent PCI were older than men. Also, ischemic mitral regurgitation (MR) and tricuspid regurgitation (TR) were more prevalent among women, while smoking was more prevalent among men.

Citing Articles

Update on Management of Cardiovascular Diseases in Women.

Luca F, Abrignani M, Parrini I, Di Fusco S, Giubilato S, Rao C J Clin Med. 2022; 11(5).

PMID: 35268267 PMC: 8911459. DOI: 10.3390/jcm11051176.

References

Weber C, Noels H . Atherosclerosis: current pathogenesis and therapeutic options. Nat Med. 2011; 17(11):1410-22. DOI: 10.1038/nm.2538. View

Kovacic J, Mehran R, Karajgikar R, Baber U, Suleman J, Kim M . Female gender and mortality after percutaneous coronary intervention: results from a large registry. Catheter Cardiovasc Interv. 2011; 80(4):514-21. DOI: 10.1002/ccd.23338. View

Guo Y, Yin F, Fan C, Wang Z . Gender difference in clinical outcomes of the patients with coronary artery disease after percutaneous coronary intervention: A systematic review and meta-analysis. Medicine (Baltimore). 2018; 97(30):e11644. PMC: 6078653. DOI: 10.1097/MD.0000000000011644. View

De Luca L, Tomai F, Verdoia M, De Luca G . Evaluation and management of special subgroups after primary percutaneous coronary intervention. Am Heart J. 2010; 160(6 Suppl):S22-7. DOI: 10.1016/j.ahj.2010.10.012. View

Hordijk-Trion M, Lenzen M, Wijns W, de Jaegere P, Simoons M, Scholte Op Reimer W . Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization. Eur Heart J. 2006; 27(6):671-8. DOI: 10.1093/eurheartj/ehi731. View

Yan F, Liu H, Jiang W . Prevalence and associated factors of mortality after percutaneous coronary intervention for adult patients with ST elevation myocardial infarction: A systematic review and meta-analysis protocol. Medicine (Baltimore). 2019; 98(26):e16226. PMC: 6617472. DOI: 10.1097/MD.0000000000016226. View

Jackson E, Moscucci M, Smith D, Share D, Dixon S, Greenbaum A . The association of sex with outcomes among patients undergoing primary percutaneous coronary intervention for ST elevation myocardial infarction in the contemporary era: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.... Am Heart J. 2010; 161(1):106-112.e1. DOI: 10.1016/j.ahj.2010.09.030. View

Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V . ESC guidelines on management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Rev Esp Cardiol. 2009; 62(3):293, e1-47. DOI: 10.1016/s1885-5857(09)71559-2. View

Hamm C, Bassand J, Agewall S, Bax J, Boersma E, Bueno H . ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment.... Eur Heart J. 2011; 32(23):2999-3054. DOI: 10.1093/eurheartj/ehr236. View

10.

Worrall-Carter L, MacIsaac A, Scruth E, Rahman M . Gender difference in the use of coronary interventions for patients with acute coronary syndrome: Experience from a major metropolitan hospital in Melbourne, Australia. Aust Crit Care. 2016; 30(1):3-10. DOI: 10.1016/j.aucc.2016.03.005. View

11.

Gudnadottir G, Andersen K, Thrainsdottir I, James S, Lagerqvist B, Gudnason T . Gender differences in coronary angiography, subsequent interventions, and outcomes among patients with acute coronary syndromes. Am Heart J. 2017; 191:65-74. DOI: 10.1016/j.ahj.2017.06.014. View

12.

Cenko E, van der Schaar M, Yoon J, Kedev S, Valvukis M, Vasiljevic Z . Sex-Specific Treatment Effects After Primary Percutaneous Intervention: A Study on Coronary Blood Flow and Delay to Hospital Presentation. J Am Heart Assoc. 2019; 8(4):e011190. PMC: 6405653. DOI: 10.1161/JAHA.118.011190. View

13.

Josiah A, Farshid A . Gender is Not a Predictor of Mortality or Major Adverse Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes. Heart Lung Circ. 2018; 28(5):727-734. DOI: 10.1016/j.hlc.2018.03.020. View

14.

Sarrafzadegan N, Mohammmadifard N . Cardiovascular Disease in Iran in the Last 40 Years: Prevalence, Mortality, Morbidity, Challenges and Strategies for Cardiovascular Prevention. Arch Iran Med. 2019; 22(4):204-210. View

15.

Lansky A, Pietras C, Costa R, Tsuchiya Y, Brodie B, Cox D . Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications.... Circulation. 2005; 111(13):1611-8. DOI: 10.1161/01.CIR.0000160362.55803.40. View

16.

OConnor G, Morton J, Diehl M, Olmstead E, COFFIN L, Levy D . Differences between men and women in hospital mortality associated with coronary artery bypass graft surgery. The Northern New England Cardiovascular Disease Study Group. Circulation. 1993; 88(5 Pt 1):2104-10. DOI: 10.1161/01.cir.88.5.2104. View

17.

Wijns W, Kolh P, Danchin N, Di Mario C, Falk V, Folliguet T . Guidelines on myocardial revascularization. Eur Heart J. 2010; 31(20):2501-55. DOI: 10.1093/eurheartj/ehq277. View

18.

Argulian E, Patel A, Abramson J, Kulkarni A, Champney K, Palmer S . Gender differences in short-term cardiovascular outcomes after percutaneous coronary interventions. Am J Cardiol. 2006; 98(1):48-53. DOI: 10.1016/j.amjcard.2006.01.048. View

19.

Heer T, Hochadel M, Schmidt K, Mehilli J, Zahn R, Kuck K . Sex Differences in Percutaneous Coronary Intervention-Insights From the Coronary Angiography and PCI Registry of the German Society of Cardiology. J Am Heart Assoc. 2017; 6(3). PMC: 5524024. DOI: 10.1161/JAHA.116.004972. View

20.

Epps K, Holper E, Selzer F, Vlachos H, Gualano S, Abbott J . Sex Differences in Outcomes Following Percutaneous Coronary Intervention According to Age. Circ Cardiovasc Qual Outcomes. 2016; 9(2 Suppl 1):S16-25. PMC: 4772169. DOI: 10.1161/CIRCOUTCOMES.115.002482. View